跳至主要内容
临床试验/NCT02606110
NCT02606110撤回不适用

Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer

Eastern Regional Medical Center1 个研究点 分布在 1 个国家开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Changes in touch and sensory by way of change in the Semmes-Weinstein Monofilament Testing

研究概览

简要总结

The purpose of this study is to investigate the effect of the ReBuilder in the treatment of individuals with breast cancer and chemotherapy induced peripheral neuropathy.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with breast cancer referred to Physical Therapy for CIPN
  • Physical Therapy Examination indicates use of Rebuilder for CIPN
  • At least 18 years of age
  • Signed informed consent for study population
  • Willingness to complete study according to protocol

排除标准

  • Patients who do not have CIPN
  • Patients <18 years of age
  • Inability to or unwilling to sign informed consent
  • Unable to read and understand the English language
  • Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism
  • More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy

结局指标

主要结局

Changes in touch and sensory by way of change in the Semmes-Weinstein Monofilament Testing

时间窗: one year

Changes in touch and sensory by way of changes in Functional Gait Assessment

时间窗: One year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Pilot Study Investigating the Use of the ReBuilder... | 临床试验